[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CN103196731A - Multiple stain reagent and detection method for identifying breast myoepithelial lesion - Google Patents

Multiple stain reagent and detection method for identifying breast myoepithelial lesion Download PDF

Info

Publication number
CN103196731A
CN103196731A CN2013101352484A CN201310135248A CN103196731A CN 103196731 A CN103196731 A CN 103196731A CN 2013101352484 A CN2013101352484 A CN 2013101352484A CN 201310135248 A CN201310135248 A CN 201310135248A CN 103196731 A CN103196731 A CN 103196731A
Authority
CN
China
Prior art keywords
section
minutes
distilled water
human monoclonal
pathology
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2013101352484A
Other languages
Chinese (zh)
Inventor
王刚平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2013101352484A priority Critical patent/CN103196731A/en
Publication of CN103196731A publication Critical patent/CN103196731A/en
Pending legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention discloses a multiple stain reagent and a detection method for identifying a breast myoepithelial lesion. The multiple stain reagent comprises 20% of mouse anti-human CK8/18 immunohistochemical monoclonal antibody, 20% of ready-to-use calmodulin mouse anti-human monoclonal antibody, 20% of ready-to-use cytokeratin mouse anti-human monoclonal antibody, 20% of ready-to-use P63 protein mouse anti-human monoclonal antibody, and 20% of actin HHF-35 anti-human monoclonal antibody. When a breast myoepithelial cell is marked, the myoepithelial cell has strong specificity and sensibility, and different target antigens in the same target cell can be identified, so that a cell nucleus, a cell membrane and a cytoplasm can be stained synchronously, the reactivity and the sensibility of the myoepithelial cell are markedly improved, basic structures of a breast acinus and a catheter can be indicated more objectively, and a good assistance effect is exerted on the diagnosis of the breast lesion.

Description

Be used for differentiating multiple staining reagent and the detection method thereof of mammary gland myoepithelium pathology
Technical field
The present invention relates to a kind of SABC reagent, especially a kind of for multiple staining reagent and the detection method thereof of differentiating mammary gland myoepithelium pathology.
Background technology
Breast tissue often contains multiple antigenic component, is expressed in cell membrane, tenuigenin and the nucleus different parts of variety classes cell.The mammary gland disease pathological diagnosis will show the not synantigen of myoepithelium, galandular epithelium tissue, often need with multiple antibody dye marker in many sections respectively, if the myoepithelium continued presence does not then have infiltrating carcinoma, if the myoepithelium negative reaction then is mammary gland infiltration cancer (except the blunt duct adenosis).Single antibody of planting shows that DCIS musculoepithelia cell born of the same parents are the jumping characteristic positive, and myoepithelium is discontinuous.If in a section, show multiple tissue antigen simultaneously, often need adopt repeatedly mark mark repeatedly a section, 5 kinds of antibody will dye for 5 times, method is loaded down with trivial details, dyeing time is long, and repeatable operation causes that easily tissue comes off in a section, also wastes time and energy from the methodology angle.
Summary of the invention
Provide a kind of for multiple staining reagent and the detection method thereof of differentiating mammary gland myoepithelium pathology at above the deficiencies in the prior art during technical assignment of the present invention.
The technical solution adopted for the present invention to solve the technical problems is: a kind of for multiple staining reagent and the detection method thereof of differentiating mammary gland myoepithelium pathology, this reagent is made up of the antibody of following weight portion: mouse-anti people CK8/18 SABC monoclonal antibody 20%, instant calmodulin mouse-anti human monoclonal antibodies 20%, instant cytokeratin mouse-anti human monoclonal antibodies 20%, instant P63 albumen mouse-anti human monoclonal antibodies 20%, actin HHF-35 mouse-anti human monoclonal antibodies 20%, its method for making is that equivalent is drawn above-mentioned each component antibody respectively, mix then, get final product at vortex mixer rotation mixing or suction pipe piping and druming mixing, and it is standby to put in 4 ℃ of refrigerators preservation.
Be used for differentiating the detection method of mammary gland myoepithelium pathology, may further comprise the steps:
Step 1, the mammary gland myoepithelium tissue of gathering through dehydration, behind the transparent and waxdip, after carrying out paraffin embedding, cut into slices, thickness is 3-5um, the tissue that is suspected to have pathology is elected to be immune labeled, is under 58 ℃-60 ℃ in temperature, be put into roasting the section 2-3 hour in the constant temperature oven, after paraffin process dewaxing in the section, the aquation, with TBS liquid flushing section 3 times, each 3 minutes;
Step 2, will cut into slices through endogenous peroxydase blocking-up, be that 3% freshly prepared hydrogen peroxide is hatched section 5 minutes with concentration, cuts into slices 2 times each 3 minutes then with distilled water flushing;
Step 3, repair liquid with EDTA antigen retrieval is carried out in section;
Step 4, tangential section add non-immune serum, hatch section 10 minutes under the room temperature;
Step 5, remove the non-immune serum in the section, tangential section is added and is redyed color reagent, hatches section 30-60 minute under 17 ℃ of-33 ℃ of temperature;
Step 6, add and make MACH 2 Double Stain ELIAS secondary antibody reagent, incubated at room section 30 minutes with TBS liquid flushing section 3 times, each 3 minutes, is used distilled water flushing 2 times, each 3 minutes again;
Step 7, remove the distilled water in the section after, added AP-red developer incubated at room section 10-20 minute, with distilled water flushing 2 times, each 3 minutes, examine under a microscope, grasp dyeing time, positive signal is red, after observation is finished, with TBS liquid flushing section 3 times, each 3 minutes, use distilled water flushing again 2 times, each 3 minutes, adopting the pH value then is 2.0, concentration was 0.05% HCl incubated at room section 30 minutes, with TBS liquid flushing section 2 times, each 3 minutes;
Step 8, add DAB developer incubated at room section after 5 minutes, with distilled water flushing section 2 times, each 3 minutes, examine under a microscope, grasp dyeing time, positive signal is yellow or pale brown look, after observation finishes, with distilled water flushing section 3 times, each 3 minutes;
Step 9, remove the distilled water in the section, add haematine understain 30-60 after second, with distilled water flushing 2 times, each 3 minutes;
Step 10, remove the distilled water in the section, when section is not dried, directly drip water-based mountant mounting, 60 ℃ of oven dry 15-30 minute after the water-based mountant drying, are treated the nature cooling, get final product with the neutral gum mounting again.
In melting point of paraffin wax described in the above-mentioned steps one less than 60 ℃.
Repair liquid for to boil 20 minutes at EDTA described in the above-mentioned steps three under 100 ℃ of temperature, its pH is 8.0.
Be matching while using at AP-red developer described in the above-mentioned steps seven.
Multiple staining reagent of the present invention has stronger specificity and susceptibility when mark mammary gland musculoepithelia cell.Can identify target antigens different in the same target cell respectively, make nucleus, cell membrane and tenuigenin painted synchronously, reactivity and the susceptibility of musculoepithelia cell have obviously been increased, more can demonstrate the basic structure of mammary gland acinus and conduit objectively, good booster action is played in the diagnosis of breast lesion.
Observe by experiment, we find that multiple staining reagent of the present invention is used for the immunohistochemistry mark and has the effect that antibody is had complementary advantages, two kinds of antibody capables react with isocellular different target antigens respectively, the common identification target cell, point out this technology that the collaborative potentiality that detect the tumor tissues source are arranged, especially help pathologic diagnosis of tumor.
This method only is applicable to antigen at present not in the double-tagging of same position, and still not being suitable for two antigens may be in same positioned detection.
Generating technique effect of the present invention is as follows:
1, can sync mark two kinds of target cells of different tissues, again can the identical target cell of mark in different target antigens;
2, avoided single mark discontinuity, jumping characteristic, this labelling method makes the myoepithelium continued labelling, is easy to detect and confirms the special mess microinvasive carcinoma, has improved repeatability and the accuracy rate of diagnosis;
3, especially in the aspiration biopsy small sample, once individual multiple dyeing of cutting into slices can reduce quite a few and fail to pinpoint a disease in diagnosis or because of the unnecessary repeated puncture biopsy of the uncertain patient of causing of diagnostic result;
4, uncontinuity and the jumping characteristic of single labelled reagent dyeing have been overcome, when making single mark musculoepithelia cell seem to be lack as or to be shown as the myoepithelium structure continuous in the structural break zone, also obviously more single mark is remarkable for its response intensity, being different from infiltration ductal carcinomas of breast does not have positive reaction, makes myoepithelium and galandular epithelium distribute and comes into plain view.
5, individual section, simultaneously different colours, improved the sharpness of color contrast;
6, new mounting method wet envelope method different from the past can be protected look for a long time, and is colour-fast;
7, easy, economic, practical, both be applicable to subject study experiment, be applicable to the clinical pathology diagnosis again, seek the tumor tissues source and have very big potentiality uniting.
Embodiment
A kind of for the multiple staining SABC reagent of differentiating mammary gland myoepithelium pathology, this SABC reagent is made up of the antibody of following weight portion: mouse-anti people CK8/18 SABC monoclonal antibody 20%, instant calmodulin mouse-anti human monoclonal antibodies 20%, instant cytokeratin mouse-anti human monoclonal antibodies 20%, instant P63 albumen mouse-anti human monoclonal antibodies 20%, actin HHF-35 mouse-anti human monoclonal antibodies 20%, its method for making is that equivalent is drawn above-mentioned each component antibody respectively, mix then, get final product at vortex mixer rotation mixing or suction pipe piping and druming mixing, and it is standby to put in 4 ℃ of refrigerators preservation.
Did the preliminary experiment of independent dyeing before carrying out multiple staining at first respectively, the condition of its experiment condition during with multiple staining is identical.
This invention multiple staining reagent immunohistochemical staining adopts the horseradish peroxidase HPR detection system with the polymkeric substance link, and concrete grammar is:
Step 1, the mammary gland myoepithelium tissue of gathering through dehydration, behind the transparent and waxdip, after carrying out low-melting paraffin (fusing point<60 ° C) embedding, cut into slices, thickness is 3-5um, the tissue that is suspected to have pathology is elected to be immune labeled, is under 58 ℃-60 ℃ in temperature, be put into roasting the section 2-3 hour in the constant temperature oven, after paraffin process dewaxing in the section, the aquation, with TBS liquid flushing section 3 times, each 3 minutes;
Step 2, will cut into slices through endogenous peroxydase blocking-up, be that 3% freshly prepared hydrogen peroxide is hatched section 5 minutes with concentration, cuts into slices 2 times each 3 minutes then with distilled water flushing;
Step 3, repair liquid with EDTA antigen retrieval is carried out in section, its EDTA repairs liquid for to boil 20 minutes under 100 ℃ of temperature, and its pH is 8.0;
Step 4, tangential section add non-immune serum, hatch section 10 minutes under the room temperature;
Step 5, remove the non-immune serum in the section, tangential section is added and is redyed color reagent, under 17 ℃ of-33 ℃ of temperature, hatch section 30-60 minute or be placed on overnight incubation in 4 ℃ of refrigerators, carry out in the environment that humidity sealing is closed, purpose is to avoid that the antibody water evaporates causes concentrating of antibody or dry in the multiple staining reagent;
Step 6, add and make MACH 2 Double Stain ELIAS secondary antibody reagent, its MACH 2 Double Stain select for use U.S. Biocare Medical company to produce, incubated at room section 30 minutes, with TBS liquid flushing section 3 times, each 3 minutes, use distilled water flushing again 2 times, each 3 minutes;
Step 7, after removing the distilled water in the section, add AP-red developer incubated at room section 10-20 minute, with distilled water flushing 2 times, each 3 minutes, examine under a microscope, grasp dyeing time according to the development of redness, positive signal is red, after observation is finished, with TBS liquid flushing section 3 times, each 3 minutes, use distilled water flushing again 2 times, each 3 minutes, adopting the pH value then was 2.0, and concentration is 0.05% HCl incubated at room section 30 minutes, purpose is the activity of all antibody in the wash-out deactivation multiple staining reagent, avoid the cross reaction that causes in the double staining, with TBS liquid flushing section 2 times, each 3 minutes;
Step 8, add DAB developer incubated at room section after 5 minutes, with distilled water flushing section 2 times, each 3 minutes, examine under a microscope, grasp dyeing time according to the development of color, positive signal is yellow or pale brown look, after observation finishes, with distilled water flushing section 3 times, each 3 minutes;
Step 9, remove the distilled water in the section, add haematine understain 30-60 after second, with distilled water flushing 2 times, each 3 minutes;
Step 10, remove the distilled water in the section, when section is not dried, directly drip water-based mountant mounting, 60 ℃ of oven dry 15-30 minute after the water-based mountant drying, are treated the nature cooling, get final product with the neutral gum mounting again.

Claims (5)

1. be used for differentiating the multiple staining reagent of mammary gland myoepithelium pathology, it is characterized in that this multiple staining reagent is made up of the antibody of following weight portion: mouse-anti people CK8/18 SABC monoclonal antibody 20%, instant calmodulin mouse-anti human monoclonal antibodies 20%, instant cytokeratin mouse-anti human monoclonal antibodies 20%, instant P63 albumen mouse-anti human monoclonal antibodies 20%, actin HHF-35 mouse-anti human monoclonal antibodies 20%, its method for making is that equivalent is drawn above-mentioned each component antibody respectively, mix then, get final product at vortex mixer rotation mixing or suction pipe piping and druming mixing, and it is standby to put in 4 ℃ of refrigerators preservation.
2. be used for differentiating the detection method of mammary gland myoepithelium pathology, it is characterized in that may further comprise the steps: step 1, the mammary gland myoepithelium tissue of gathering through dehydration, behind the transparent and waxdip, after carrying out paraffin embedding, cut into slices, thickness is 3-5um, be elected to be immune labeled to the tissue that is suspected to have pathology, be under 58 ℃-60 ℃ in temperature, be put in the constant temperature oven roasting section 2-3 hour, the paraffin in the section through dewaxing, aquation after, with TBS liquid flushing section 3 times, each 3 minutes; Step 2, will cut into slices through endogenous peroxydase blocking-up, be that 3% freshly prepared hydrogen peroxide is hatched section 5 minutes with concentration, cuts into slices 2 times each 3 minutes then with distilled water flushing; Step 3, repair liquid with EDTA antigen retrieval is carried out in section; Step 4, tangential section add non-immune serum, hatch section 10 minutes under the room temperature; Step 5, remove the non-immune serum in the section, tangential section is added and is redyed color reagent, hatches section 30-60 minute under 17 ℃ of-33 ℃ of temperature; Step 6, add and make MACH 2 Double Stain ELIAS secondary antibody reagent, incubated at room section 30 minutes with TBS liquid flushing section 3 times, each 3 minutes, is used distilled water flushing 2 times, each 3 minutes again; Step 7, remove the distilled water in the section after, added AP-red developer incubated at room section 10-20 minute, with distilled water flushing 2 times, each 3 minutes, examine under a microscope, grasp dyeing time, positive signal is red, after observation is finished, with TBS liquid flushing section 3 times, each 3 minutes, use distilled water flushing again 2 times, each 3 minutes, adopting the pH value then is 2.0, concentration was 0.05% HCl incubated at room section 30 minutes, with TBS liquid flushing section 2 times, each 3 minutes; Step 8, add DAB developer incubated at room section after 5 minutes, with distilled water flushing section 2 times, each 3 minutes, examine under a microscope, grasp dyeing time, positive signal is yellow or pale brown look, after observation finishes, with distilled water flushing section 3 times, each 3 minutes; Step 9, remove the distilled water in the section, add haematine understain 30-60 after second, with distilled water flushing 2 times, each 3 minutes; Step 10, remove the distilled water in the section, when section is not dried, directly drip water-based mountant mounting, 60 ℃ of oven dry 15-30 minute after the water-based mountant drying, are treated the nature cooling, get final product with the neutral gum mounting again.
3. according to claim 2 for the detection method of differentiating mammary gland myoepithelium pathology, it is characterized in that in melting point of paraffin wax described in the step 1 less than 60 ℃.
4. according to claim 2 for the detection method of differentiating mammary gland myoepithelium pathology, it is characterized in that repairing liquid under 100 ℃ of temperature, to boil 20 minutes at EDTA described in the step 3, its pH is 8.0.
5. according to claim 2 for the detection method of differentiating mammary gland myoepithelium pathology, it is characterized in that at the developer of AP-red described in the step 7 be matching while using.
CN2013101352484A 2013-04-18 2013-04-18 Multiple stain reagent and detection method for identifying breast myoepithelial lesion Pending CN103196731A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2013101352484A CN103196731A (en) 2013-04-18 2013-04-18 Multiple stain reagent and detection method for identifying breast myoepithelial lesion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2013101352484A CN103196731A (en) 2013-04-18 2013-04-18 Multiple stain reagent and detection method for identifying breast myoepithelial lesion

Publications (1)

Publication Number Publication Date
CN103196731A true CN103196731A (en) 2013-07-10

Family

ID=48719424

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2013101352484A Pending CN103196731A (en) 2013-04-18 2013-04-18 Multiple stain reagent and detection method for identifying breast myoepithelial lesion

Country Status (1)

Country Link
CN (1) CN103196731A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104447994A (en) * 2014-12-05 2015-03-25 福州迈新生物技术开发有限公司 Tumor suppressor gene p63 monoclonal antibody and application thereof
CN108918493A (en) * 2018-07-24 2018-11-30 中国科学院深圳先进技术研究院 A kind of pH fluorescent dye, pH fluorescence probe, preparation method and application
CN110850094A (en) * 2019-11-22 2020-02-28 西安交通大学 Immunohistochemical double-label single-staining kit and use method and application thereof
CN112964877A (en) * 2021-03-09 2021-06-15 河南赛诺特生物技术有限公司 Immunohistochemical multiple staining kit and staining procedure for identifying mantle cell lymphoma
CN113295871A (en) * 2021-07-02 2021-08-24 河南赛诺特生物技术有限公司 Cocktail immunohistochemical kit for diagnosing breast cancer
CN113762379A (en) * 2021-09-07 2021-12-07 福州迈新生物技术开发有限公司 Method for generating training data based on immunohistochemistry and storage device
CN116086919A (en) * 2023-02-20 2023-05-09 深圳裕策生物科技有限公司 Staining method and kit for lung cancer and/or pancreatic cancer samples

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN87101075A (en) * 1987-06-29 1988-04-20 蒋俊辉 Whole dyeing technique of one step of plant tissue polychrome and special combination stain thereof
CN1360059A (en) * 2000-12-18 2002-07-24 拜尔公司 Method for specific detection of tumor cell and its precursor in cervix smear by simultaneously measuring at least two different molecular labels
CN101329230A (en) * 2008-07-14 2008-12-24 中国人民解放军第三军医大学 Improved method for dyeing immunofluorescence cell
CN101395182A (en) * 2006-03-06 2009-03-25 西福根有限公司 Recombinant antibodies for treatment of respiratory syncytial virus infections
CN101545911A (en) * 2008-03-25 2009-09-30 北京科美东雅生物技术有限公司 Chemoluminescence immunoassay quantitative measuring kit of cytokeratin 18 and preparation method thereof
JP2010148447A (en) * 2008-12-25 2010-07-08 Canon Inc Composition for staining retinal tissue and method for staining retinal tissue
US20100322502A1 (en) * 2009-06-18 2010-12-23 Olympus Corporation Medical diagnosis support device, image processing method, image processing program, and virtual microscope system
CN102405238A (en) * 2009-04-20 2012-04-04 国立大学法人富山大学 Antibody cocktail for determining cancer histological type, determination kit and determination method
CN102924594A (en) * 2012-08-03 2013-02-13 无锡傲锐东源生物科技有限公司 Anti-tumor-protein-P63 monoclonal antibody and purpose thereof

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN87101075A (en) * 1987-06-29 1988-04-20 蒋俊辉 Whole dyeing technique of one step of plant tissue polychrome and special combination stain thereof
CN1360059A (en) * 2000-12-18 2002-07-24 拜尔公司 Method for specific detection of tumor cell and its precursor in cervix smear by simultaneously measuring at least two different molecular labels
CN101395182A (en) * 2006-03-06 2009-03-25 西福根有限公司 Recombinant antibodies for treatment of respiratory syncytial virus infections
CN101545911A (en) * 2008-03-25 2009-09-30 北京科美东雅生物技术有限公司 Chemoluminescence immunoassay quantitative measuring kit of cytokeratin 18 and preparation method thereof
CN101329230A (en) * 2008-07-14 2008-12-24 中国人民解放军第三军医大学 Improved method for dyeing immunofluorescence cell
JP2010148447A (en) * 2008-12-25 2010-07-08 Canon Inc Composition for staining retinal tissue and method for staining retinal tissue
CN102405238A (en) * 2009-04-20 2012-04-04 国立大学法人富山大学 Antibody cocktail for determining cancer histological type, determination kit and determination method
US20100322502A1 (en) * 2009-06-18 2010-12-23 Olympus Corporation Medical diagnosis support device, image processing method, image processing program, and virtual microscope system
CN102924594A (en) * 2012-08-03 2013-02-13 无锡傲锐东源生物科技有限公司 Anti-tumor-protein-P63 monoclonal antibody and purpose thereof

Non-Patent Citations (12)

* Cited by examiner, † Cited by third party
Title
CHRIS M. VAN DER LOOS: "Multiple Immunoenzyme Staining: Methods and Visualizations for the Observation With Spectral Imaging", 《JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY》 *
I. SELICHAROVÁ ET AL.: "2-DE analysis of a new human cell line EM-G3 derived from breast cancer progenitor cells and comparison with normal mammary epithelial cells", 《PROTEOMICS 2007》 *
KUSAFUKA ET AL.: "Dedifferentiated epithelial-myoepithelial carcinoma of the parotid gland: a rare case report of immunohistochemical analysis and review of the literature", 《OOOOE》 *
MARIA M.HO,ET AL.: "Side Population in Human Lung Cancer Cell Lines and Tumors Is Enriched with Stem-like Cancer Cells", 《CANCER RES2010》 *
PHILIP S.RUDLAND,ET AL.: "Immunocytochemical Identification of Cell Types in Benign and Malignant Breast Diseases: Variations in Cell Markers Accompany the Malignant State", 《TBEJOUMAL OF HISTOCHEMISTRY AND CYTOCHEMISTRY》 *
RAJAN DEWAR, MD, PHD,ET AL.: "Best Practices in Diagnostic Immunohistochemistry—Myoepithelial Markers in Breast Pathology", 《ARCH PATHOL LAB MED》 *
RAKHA E A, EL-SAYED M E, GREEN A R, PAISH E C, LEE A H S & ELLIS: "Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression", 《HISTOPATHOLOGY 2007》 *
SUSAN VAN NOORDEN,ET AL.: "Localization of Human Pituitary Hormones by Multiple Immunoenzyme Staining Procedures Using Monoclonal and Polyclonal Antibodies1", 《THE JOURNAL OF HISTOCHEMISTRY AND CYTOCHEMISTRY》 *
卢晓梅 等: "p63 显示肌上皮细胞在乳腺癌诊断中价值", 《临床与实验病理学杂志》 *
师锁柱 等: "微波石蜡切片免疫荧光多重标记技术在肾活检病理诊断中的应用", 《中国中西医结合肾病杂志》 *
王翠芝 等: "混合型p504s /34BE12 /p63抗体在前列腺腺癌诊断中的应用价值", 《临床与实验病理学杂志》 *
董丹丹 等: "P63/α-SMA鸡尾酒法标记肌上皮细胞在诊断乳腺导管原位癌和浸润性癌中的应用", 《实用医院临床杂志》 *

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104447994B (en) * 2014-12-05 2018-05-04 福州迈新生物技术开发有限公司 One plant of tumor suppressor gene p63 monoclonal antibody and its application
CN104447994A (en) * 2014-12-05 2015-03-25 福州迈新生物技术开发有限公司 Tumor suppressor gene p63 monoclonal antibody and application thereof
CN108918493A (en) * 2018-07-24 2018-11-30 中国科学院深圳先进技术研究院 A kind of pH fluorescent dye, pH fluorescence probe, preparation method and application
CN110850094A (en) * 2019-11-22 2020-02-28 西安交通大学 Immunohistochemical double-label single-staining kit and use method and application thereof
CN112964877A (en) * 2021-03-09 2021-06-15 河南赛诺特生物技术有限公司 Immunohistochemical multiple staining kit and staining procedure for identifying mantle cell lymphoma
CN113295871B (en) * 2021-07-02 2023-07-21 河南赛诺特生物技术有限公司 Cocktail immunohistochemical kit for diagnosing breast cancer
CN113295871A (en) * 2021-07-02 2021-08-24 河南赛诺特生物技术有限公司 Cocktail immunohistochemical kit for diagnosing breast cancer
CN113762379A (en) * 2021-09-07 2021-12-07 福州迈新生物技术开发有限公司 Method for generating training data based on immunohistochemistry and storage device
CN114674644A (en) * 2021-09-07 2022-06-28 福州迈新生物技术开发有限公司 Method for generating training data based on immunohistochemistry and storage device
WO2023035728A1 (en) * 2021-09-07 2023-03-16 福州迈新生物技术开发有限公司 Method for generating training data based on immunohistochemistry, and storage device
CN113762379B (en) * 2021-09-07 2022-06-07 福州迈新生物技术开发有限公司 Method for generating training data based on immunohistochemistry and storage device
CN114674644B (en) * 2021-09-07 2024-08-27 福州迈新生物技术开发有限公司 Method and storage device for generating training data based on immunohistochemistry
CN116086919A (en) * 2023-02-20 2023-05-09 深圳裕策生物科技有限公司 Staining method and kit for lung cancer and/or pancreatic cancer samples
CN116086919B (en) * 2023-02-20 2024-01-26 深圳裕策生物科技有限公司 Staining method and kit for lung cancer and/or pancreatic cancer samples

Similar Documents

Publication Publication Date Title
CN103196731A (en) Multiple stain reagent and detection method for identifying breast myoepithelial lesion
US20210047697A1 (en) Method for improved diagnosis of dysplasias
CN104977202B (en) A kind of transmission electron microscope sample preparation method of specimens paraffin embedding slices tissue
CN107202888B (en) A kind of p16 for cervical liquid-based cellsINK4aImmune labeled colour reagent box
CN101598731B (en) Immune tissue chemical diagnostic kit used for pathological diagnosis of tumour
US20150309035A1 (en) Antibody Cocktail Systems and Methods for Classification of Histologic Subtypes in Lung Cancer
CN104237538A (en) Dairy cow milk progesterone colloidal gold test paper strip and preparation method thereof
WO2023035728A1 (en) Method for generating training data based on immunohistochemistry, and storage device
WO2014114009A1 (en) Immunohistochemical quality control reference object and quality control method
JP5370826B2 (en) Cocktail antibody, discrimination kit and discrimination method for discriminating cancer tissue type
CN110850094A (en) Immunohistochemical double-label single-staining kit and use method and application thereof
CN106153922B (en) A kind of colon cancer prognosis prediction mark and its detection method
CN102435728A (en) Preparation method of positive reference substance for quality inspection and control in immunohistochemical process
CN103471903B (en) The collocation method of section immobile liquid and application thereof
CN106053806A (en) HPV (human papillomavirus) immune colloidal gold diagnostic test strip, method for preparing same and detection method implemented by HPV immune colloidal gold diagnostic test strip
WO2014117332A1 (en) Method for determining sensitivity and affinity of secondary antibody color appearance system for immunohistochemistry
CN105891511A (en) Probe and kit for identifying circulating tumor cells and neutrophils
JP2021517242A (en) How to detect MAGEA4
CN106397583A (en) POCT (point-of-care testing) fluorescent quantitative test kit for HPV16 type E7 protein and application thereof
CN101738474B (en) Combined test reagent card for cytomegalovirus and rubella virus
Okazaki et al. CD146 and insulin‐like growth factor 2 mRNA‐binding protein 3 predict prognosis of asbestos‐induced rat mesothelioma
CN108957004B (en) Application of reagent for detecting expression levels of H3K9me2 and H3K36me3 in preparation of gastric cancer prognosis evaluation kit
CN113567677B (en) Immunofluorescence signal amplification technology marking method
CN111929122B (en) Antigen repairing method for immunocytochemical staining, cell suspension and chemical staining method using same
JP3222251U (en) Immunodiafiltration apparatus for detecting serum fucose protein

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C05 Deemed withdrawal (patent law before 1993)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130710